# Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury

> **NCT01212679** · PHASE2 · COMPLETED · sponsor: **Jinling Hospital, China** · enrollment: 106 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **DRUG:** nerve growth factor
- **DRUG:** nomral saline

## Key facts

- **NCT ID:** NCT01212679
- **Lead sponsor:** Jinling Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212679, "Effects of Intranasal Nerve Growth Factor for Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01212679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*